Table 3 Baseline and post-treatment VA by eyes affected for HIV-positive patients with CMVR treated at MTY Clinic, Myanmar, 2013–2017
Total (N = 72) | Local treatment (N = 31) | Systemic treatment (N = 41) | ||||
|---|---|---|---|---|---|---|
Pre-Rx N (%) | Post-Rx N (%) | Pre-Rx N (%) | Post-Rx N (%) | Pre-Rx N (%) | Post-Rx N (%) | |
Mild/none | 53 (74) | 44 (61) | 24 (77) | 16 (52) | 29 (71) | 28 (68) |
Moderate | 9 (12.5) | 6 (8) | 2 (6) | 3 (10) | 7 (17) | 3 (7) |
Severe | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Blind | 9 (12.5) | 7 (10) | 5 (16) | 5 (16) | 4 (10) | 2 (5) |
Unknown | 1 (1) | 4 (6) | 0 (0) | 1 (3) | 1 (2) | 3 (7) |
Deceased/LTFU | 0 (0) | 11 (15) | 0 (0) | 6 (19) | 0 (0) | 5 (12) |